FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ann Arvin

Research Profile

Living Beings

Disorders

Chemicals & Drugs

Anatomy

Physiology

Procedures

Transplantation, Heterologous

Genes & Molecular Sequences

Open Reading Frames

Co-author Network

Publications

TOP 3
Xibing Che; Jürgen Haas; Stefan L Oliver; Mike Reichelt; Tihana L Rovis; Marvin H Sommer; Ann M Arvin
ORF11 Protein Interacts with the ORF9 Essential Tegument Protein in Varicella-Zoster Virus Infection.
Li Wang; Leigh Zerboni; Jaya Rajamani; Marvin Sommer; Ann M Arvin
Identification of a hydrophobic domain in varicella-zoster virus ORF61 necessary for ORF61 self-interaction, viral replication, and skin pathogenesis.
Hayley Gans; Barbara Sullivan; Phillip Sung; Linda L Yasukawa; Susette Audet; Judy A Beeler; Ross DeHovitz; Ann M Arvin
Measles humoral and cell-mediated immunity in children aged 5-10 years after primary measles immunization administered at 6 or 9 months of age.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ann Arvin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Xibing Che; Jürgen Haas; Stefan L Oliver; Mike Reichelt; Tihana L Rovis; Marvin H Sommer; Ann M Arvin
ORF11 Protein Interacts with the ORF9 Essential Tegument Protein in Varicella-Zoster Virus Infection.
Journal of virology 2013;87(9):5106-17.
2013: Li Wang; Leigh Zerboni; Jaya Rajamani; Marvin Sommer; Ann M Arvin
Identification of a hydrophobic domain in varicella-zoster virus ORF61 necessary for ORF61 self-interaction, viral replication, and skin pathogenesis.
Journal of virology 2013;87(7):4075-9.
2013: Hayley Gans; Barbara Sullivan; Phillip Sung; Linda L Yasukawa; Susette Audet; Judy A Beeler; Ross DeHovitz; Ann M Arvin
Measles humoral and cell-mediated immunity in children aged 5-10 years after primary measles immunization administered at 6 or 9 months of age.
The Journal of infectious diseases 2013;207(4):574-82.
2013: Stefan L Oliver; Mike Reichelt; Marvin H Sommer; Phillip Sung; Helen M Blau; Jennifer J Brady; Ann M Arvin
An immunoreceptor tyrosine-based inhibition motif in varicella-zoster virus glycoprotein B regulates cell fusion and skin pathogenesis.
Proceedings of the National Academy of Sciences of the United States of America 2013;110(5):1911-6.
2012: Mike Reichelt; Lydia Joubert; Ai Leen Koh; John Perrino; Ibanri Phanwar; Ann M Arvin
3D reconstruction of VZV infected cell nuclei and PML nuclear cages by serial section array scanning electron microscopy and electron tomography.
PLoS pathogens 2012;8(6):e1002740.
2011: Susan E Vleck; Helen M Blau; Jennifer J Brady; Stefan L Oliver; Jaya Rajamani; Marvin H Sommer; Ann M Arvin
Structure-function analysis of varicella-zoster virus glycoprotein H identifies domain-specific roles for fusion and skin tropism.
Proceedings of the National Academy of Sciences of the United States of America 2011;108(45):18412-7.
2011: Li Wang; Stefan L Oliver; Jaya Rajamani; Mike Reichelt; Marvin Sommer; Ann M Arvin
Disruption of PML nuclear bodies is mediated by ORF61 SUMO-interacting motifs and required for varicella-zoster virus pathogenesis in skin.
PLoS pathogens 2011;7(8):e1002157.
2011: Adel M Nour; Mike Reichelt; Chia-Chi Ku; Min-Yin Ho; Thomas C Heineman; Ann M Arvin
Varicella-zoster virus infection triggers formation of an interleukin-1β (IL-1β)-processing inflammasome complex.
The Journal of biological chemistry 2011;286(20):17921-33.
2011: Stefan L Oliver; Marvin H Sommer; Mike Reichelt; Jaya Rajamani; Leonssia Vlaycheva-Beisheim; Shaye Stamatis; Jason Cheng; Carol Jones; James Zehnder; Ann M Arvin
Mutagenesis of varicella-zoster virus glycoprotein I (gI) identifies a cysteine residue critical for gE/gI heterodimer formation, gI structure, and virulence in skin cells.
Journal of virology 2011;85(9):4095-110.
2011: Mike Reichelt; Li Wang; Marvin Sommer; John Perrino; adel nour; Nandini Sen; Armin Baiker; Leigh Zerboni; Ann M Arvin
Entrapment of viral capsids in nuclear PML cages is an intrinsic antiviral host defense against varicella-zoster virus.
PLoS pathogens 2011;7(2):e1001266.
2011: Leigh Zerboni; Barbara Berarducci; Jaya Rajamani; Carol D Jones; James L Zehnder; Ann M Arvin
Varicella-zoster virus glycoprotein E is a critical determinant of virulence in the SCID mouse-human model of neuropathogenesis.
Journal of virology 2011;85(1):98-111.
2010: Nandini Sen; Marvin Sommer; Xibing Che; Kris White; William T Ruyechan; Ann M Arvin
Varicella-zoster virus immediate-early protein 62 blocks interferon regulatory factor 3 (IRF3) phosphorylation at key serine residues: a novel mechanism of IRF3 inhibition among herpesviruses.
Journal of virology 2010;84(18):9240-53.
2010: Jennifer H Huch; Anthony L Cunningham; Ann M Arvin; Najla Nasr; Saskia J A M Santegoets; Eric Slobedman; Barry Slobedman; Allison Abendroth
Impact of varicella-zoster virus on dendritic cell subsets in human skin during natural infection.
Journal of virology 2010;84(8):4060-72.
2010: Barbara Berarducci; Jaya Rajamani; Leigh Zerboni; Xibing Che; Marvin Sommer; Ann M Arvin
Functions of the unique N-terminal region of glycoprotein E in the pathogenesis of varicella-zoster virus infection.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(1):282-7.
2010: Allison Abendroth; Ann M Arvin; Jennifer F Moffat
Varicella-zoster virus. Preface.
Current topics in microbiology and immunology 2010;342():v-vi.
2010: Ann M Arvin; Jennifer F Moffat; Marvin Sommer; Stefan Oliver; Xibing Che; Susan Vleck; Leigh Zerboni; Chia-Chi Ku
Varicella-zoster virus T cell tropism and the pathogenesis of skin infection.
Current topics in microbiology and immunology 2010;342():189-209.
2010: Ann M Arvin; Stefan Oliver; Mike Reichelt; Jennifer F Moffat; Marvin Sommer; Leigh Zerboni; Barbara Berarducci
Analysis of the functions of glycoproteins E and I and their promoters during VZV replication in vitro and in skin and T-cell xenografts in the SCID mouse model of VZV pathogenesis.
Current topics in microbiology and immunology 2010;342():129-46.
2010: Susan E Vleck; Stefan L Oliver; Mike Reichelt; Jaya Rajamani; Leigh Zerboni; Carol Jones; James L Zehnder; Charles Grose; Ann M Arvin
Anti-glycoprotein H antibody impairs the pathogenicity of varicella-zoster virus in skin xenografts in the SCID mouse model.
Journal of virology 2010;84(1):141-52.
2009: Rima Hanna-Wakim; Linda L Yasukawa; Phillip Sung; Mimi Fang; Barbara Sullivan; Mary Rinki; Ross DeHovitz; Ann M Arvin; Hayley Gans
Age-related increase in the frequency of CD4(+) T cells that produce interferon-gamma in response to staphylococcal enterotoxin B during childhood.
The Journal of infectious diseases 2009;200(12):1921-7.
2009: Stefan L Oliver; Marvin Sommer; Leigh Zerboni; Jaya Rajamani; Charles Grose; Ann M Arvin
Mutagenesis of varicella-zoster virus glycoprotein B: putative fusion loop residues are essential for viral replication, and the furin cleavage motif contributes to pathogenesis in skin tissue in vivo.
Journal of virology 2009;83(15):7495-506.
2009: Li Wang; Marvin Sommer; Jaya Rajamani; Ann M Arvin
Regulation of the ORF61 promoter and ORF61 functions in varicella-zoster virus replication and pathogenesis.
Journal of virology 2009;83(15):7560-72.
2009: Candice K Smith; Ann M Arvin
Varicella in the fetus and newborn.
Seminars in fetal & neonatal medicine 2009;14(4):209-17.
2009: Mike Reichelt; Jennifer Brady; Ann M Arvin
The replication cycle of varicella-zoster virus: analysis of the kinetics of viral protein expression, genome synthesis, and virion assembly at the single-cell level.
Journal of virology 2009;83(8):3904-18.
2009: Barbara Berarducci; Jaya Rajamani; Mike Reichelt; Marvin Sommer; Leigh Zerboni; Ann M Arvin
Deletion of the first cysteine-rich region of the varicella-zoster virus glycoprotein E ectodomain abolishes the gE and gI interaction and differentially affects cell-cell spread and viral entry.
Journal of virology 2009;83(1):228-40.
2008: Stefan L Oliver; Leigh Zerboni; Marvin Sommer; Jaya Rajamani; Ann M Arvin
Development of recombinant varicella-zoster viruses expressing luciferase fusion proteins for live in vivo imaging in human skin and dorsal root ganglia xenografts.
Journal of virological methods 2008;154(1-2):182-93.
2008: Vaishali Chaudhuri; Marvin Sommer; Jaya Rajamani; Leigh Zerboni; Ann M Arvin
Functions of Varicella-zoster virus ORF23 capsid protein in viral replication and the pathogenesis of skin infection.
Journal of virology 2008;82(20):10231-46.
2008: Rima Hanna-Wakim; Linda L Yasukawa; Phillip Sung; Ann M Arvin; Hayley Gans
Immune responses to mumps vaccine in adults who were vaccinated in childhood.
The Journal of infectious diseases 2008;197(12):1669-75.
2008: Hayley Gans; Linda L Yasukawa; Cathryn Z Zhang; Rima Hanna Wakim; Mary Rinki; Ross DeHovitz; Ann M Arvin
Effects of interleukin-12 and interleukin-15 on measles-specific T-cell responses in vaccinated infants.
Viral immunology 2008;21(2):163-72.
2008: Xibing Che; Mike Reichelt; Marvin H Sommer; Jaya Rajamani; Leigh Zerboni; Ann M Arvin
Functions of the ORF9-to-ORF12 gene cluster in varicella-zoster virus replication and in the pathogenesis of skin infection.
Journal of virology 2008;82(12):5825-34.
2008: David E Michalik; Sharon P Steinberg; Philip S LaRussa; Kathryn M Edwards; Peter F Wright; Ann M Arvin; Haley A Gans; Anne A Gershon
Primary vaccine failure after 1 dose of varicella vaccine in healthy children.
The Journal of infectious diseases 2008;197(7):944-9.
2008: Mike Reichelt; Leigh Zerboni; Ann M Arvin
Mechanisms of varicella-zoster virus neuropathogenesis in human dorsal root ganglia.
Journal of virology 2008;82(8):3971-83.
2008: Xiaosong He; Tyson H Holmes; Kutubuddin Mahmood; George W Kemble; Cornelia L Dekker; Ann M Arvin; Harry B Greenberg
Phenotypic changes in influenza-specific CD8+ T cells after immunization of children and adults with influenza vaccines.
The Journal of infectious diseases 2008;197(6):803-11.
2008: Ann M Arvin
Humoral and cellular immunity to varicella-zoster virus: an overview.
The Journal of infectious diseases 2008;197 Suppl 2():S58-60.
2008: Anne A Gershon; Ann M Arvin; Myron J Levin; Jane F Seward; D Scott Schmid
Varicella vaccine in the United States: a decade of prevention and the way forward.
The Journal of infectious diseases 2008;197 Suppl 2():S39-40.
2008: Sanae Sasaki; Xiaosong He; Tyson H Holmes; Cornelia L Dekker; George W Kemble; Ann M Arvin; Harry B Greenberg
Influence of prior influenza vaccination on antibody and B-cell responses.
PloS one 2008;3(8):e2975.
2008: Xiaosong He; Tyson H Holmes; Sanae Sasaki; María C Jaimes; George W Kemble; Cornelia L Dekker; Ann M Arvin; Harry B Greenberg
Baseline levels of influenza-specific CD4 memory T-cells affect T-cell responses to influenza vaccines.
PloS one 2008;3(7):e2574.
2007: B Karsten Tischer; Benedikt Kaufer; Marvin Sommer; Felix Wussow; Ann M Arvin; Nikolaus Osterrieder
A self-excisable infectious bacterial artificial chromosome clone of varicella-zoster virus allows analysis of the essential tegument protein encoded by ORF9.
Journal of virology 2007;81(23):13200-8.
2007: Nitya Nair; Hayley Gans; Linda Lew-Yasukawa; Andrea C Long-Wagar; Ann M Arvin; Diane E Griffin
Age-dependent differences in IgG isotype and avidity induced by measles vaccine received during the first year of life.
The Journal of infectious diseases 2007;196(9):1339-45.
2007: Barbara Berarducci; Marvin Sommer; Leigh Zerboni; Jaya Rajamani; Ann M Arvin
Cellular and viral factors regulate the varicella-zoster virus gE promoter during viral replication.
Journal of virology 2007;81(19):10258-67.
2007: Zhen Zhang; Jenny Rowe; Weijia Wang; Marvin Sommer; Ann M Arvin; Jennifer F Moffat; Hua Zhu
Genetic analysis of varicella-zoster virus ORF0 to ORF4 by use of a novel luciferase bacterial artificial chromosome system.
Journal of virology 2007;81(17):9024-33.
2007: Leigh Zerboni; Mike Reichelt; Carol D Jones; James L Zehnder; Hideki Ito; Ann M Arvin
Aberrant infection and persistence of varicella-zoster virus in human dorsal root ganglia in vivo in the absence of glycoprotein I.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(35):14086-91.
2007: Anne A Gershon; Ann M Arvin; Eugene Shapiro
Varicella vaccine.
The New England journal of medicine 2007;356(25):2648-9; author reply 2648-9.
2007: Xibing Che; Barbara Berarducci; Marvin Sommer; William T Ruyechan; Ann M Arvin
The ubiquitous cellular transcriptional factor USF targets the varicella-zoster virus open reading frame 10 promoter and determines virulence in human skin xenografts in SCIDhu mice in vivo.
Journal of virology 2007;81(7):3229-39.
2007: Alenka M Zeman; Tyson H Holmes; Shaye Stamatis; Wenwei Tu; Xiaosong He; Nancy Bouvier; George W Kemble; Harry B Greenberg; David B Lewis; Ann M Arvin; Cornelia L Dekker
Humoral and cellular immune responses in children given annual immunization with trivalent inactivated influenza vaccine.
The Pediatric infectious disease journal 2007;26(2):107-15.
2007: Elizabeth L Brown; Carolyn Gardella; Gunilla Malm; Charles G Prober; Marianne Forsgren; Elizabeth Krantz; Ann M Arvin; Linda L Yasukawa; Kathleen Mohan; Zane Brown; Lawrence Corey; Anna Wald
Effect of maternal herpes simplex virus (HSV) serostatus and HSV type on risk of neonatal herpes.
Acta obstetricia et gynecologica Scandinavica 2007;86(5):523-9.
2007: Sanae Sasaki; María C Jaimes; Tyson H Holmes; Cornelia L Dekker; Kutubuddin Mahmood; George W Kemble; Ann M Arvin; Harry B Greenberg
Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines.
Journal of virology 2007;81(1):215-28.
2006: Xiaosong He; Tyson H Holmes; Caiqiu Zhang; Kutubuddin Mahmood; George W Kemble; David B Lewis; Cornelia L Dekker; Harry B Greenberg; Ann M Arvin
Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines.
Journal of virology 2006;80(23):11756-66.
2006: Anne Schaap-Nutt; Marvin Sommer; Xibing Che; Leigh Zerboni; Ann M Arvin
ORF66 protein kinase function is required for T-cell tropism of varicella-zoster virus in vivo.
Journal of virology 2006;80(23):11806-16.
2006: Ann M Arvin
Investigations of the pathogenesis of Varicella zoster virus infection in the SCIDhu mouse model.
Herpes : the journal of the IHMF 2006;13(3):75-80.
2006: Barbara Berarducci; Minako Ikoma; Shaye Stamatis; Marvin Sommer; Charles Grose; Ann M Arvin
Essential functions of the unique N-terminal region of the varicella-zoster virus glycoprotein E ectodomain in viral replication and in the pathogenesis of skin infection.
Journal of virology 2006;80(19):9481-96.
2006: Nicola P Klein; Tyson H Holmes; Margaret A Sharp; Thomas C Heineman; Mark R Schleiss; David I Bernstein; George W Kemble; Ann M Arvin; Cornelia L Dekker
Variability and gender differences in memory T cell immunity to varicella-zoster virus in healthy adults.
Vaccine 2006;24(33-34):5913-8.
2006: Elizabeth L Brown; Rhoda Ashley Morrow; Elizabeth Krantz; Ann M Arvin; Charles G Prober; Linda L Yasukawa; Lawrence Corey; Anna Wald
Maternal herpes simplex virus antibody avidity and risk of neonatal herpes.
American journal of obstetrics and gynecology 2006;195(1):115-20.
2006: Ann M Arvin; Anne A Gershon
Control of varicella: why is a two-dose schedule necessary?
The Pediatric infectious disease journal 2006;25(6):475-6.
2006: Jeremy O Jones; Ann M Arvin
Inhibition of the NF-kappaB pathway by varicella-zoster virus in vitro and in human epidermal cells in vivo.
Journal of virology 2006;80(11):5113-24.
2006: Thomas C Heineman; Mark R Schleiss; David I Bernstein; Richard Spaete; Lihan Yan; Gregory M Duke; Mark Prichard; Zhaoti Wang; Qing Yan; Margaret A Sharp; Nicola Klein; Ann M Arvin; George W Kemble
A phase 1 study of 4 live, recombinant human cytomegalovirus Towne/Toledo chimeric vaccines.
The Journal of infectious diseases 2006;193(10):1350-60.
2006: Xibing Che; Leigh Zerboni; Marvin H Sommer; Ann M Arvin
Varicella-zoster virus open reading frame 10 is a virulence determinant in skin cells but not in T cells in vivo.
Journal of virology 2006;80(7):3238-48.
2006: Jeremy O Jones; Marvin Sommer; Shaye Stamatis; Ann M Arvin
Mutational analysis of the varicella-zoster virus ORF62/63 intergenic region.
Journal of virology 2006;80(6):3116-21.
2006: Rosa María Wong-Chew; Rocío Islas-Romero; María de Lourdes García García; Judy A Beeler; Susette Audet; Jose Ignacio Santos-Preciado; Hayley Gans; Linda Lew-Yasukawa; Yvonne Maldonado; Ann M Arvin; José Luis Valdespino-Gómez
Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children.
Vaccine 2006;24(5):683-90.
2006: Ann M Arvin; Harry B Greenberg
New viral vaccines.
Virology 2006;344(1):240-9.
2006: Chantelle Ahlenstiel; Anthony L Cunningham; Barry Slobedman; Ann M Arvin; Marvin H Sommer; Paul R Kinchington; Allison Abendroth
Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons.
Journal of virology 2006;80(2):1025-31.
2005: Jennifer M Best; Carlos Castillo-Solorzano; John Spika; Joseph P Icenogle; John W Glasser; Nigel J Gay; Jon Kim Andrus; Ann M Arvin
Reducing the global burden of congenital rubella syndrome: report of the World Health Organization Steering Committee On Research Related To Measles and Rubella Vaccines and Vaccination, June 2004.
The Journal of infectious diseases 2005;192(11):1890-7.
2005: Jeremy O Jones; Ann M Arvin
Viral and cellular gene transcription in fibroblasts infected with small plaque mutants of varicella-zoster virus.
Antiviral research 2005;68(2):56-65.
2005: Anne Schaap; Jean-Francois Fortin; Marvin Sommer; Leigh Zerboni; Shaye Stamatis; Chia-Chi Ku; Garry P Nolan; Ann M Arvin
T-cell tropism and the role of ORF66 protein in pathogenesis of varicella-zoster virus infection.
Journal of virology 2005;79(20):12921-33.
2005: Charles M Helms; Fernando A Guerra; Jerome O Klein; William Schaffner; Ann M Arvin; Georges Peter
Strengthening the nation's influenza vaccination system: a National Vaccine Advisory Committee assessment.
American journal of preventive medicine 2005;29(3):221-6.
2005: Tricia Zuranski; Hesham F Nawar; Donna Czechowski; Jennifer M Lynch; Ann M Arvin; John Hay; William T Ruyechan
Cell-type-dependent activation of the cellular EF-1alpha promoter by the varicella-zoster virus IE63 protein.
Virology 2005;338(1):35-42.
2005: Ann M Arvin
Aging, immunity, and the varicella-zoster virus.
The New England journal of medicine 2005;352(22):2266-7.
2005: Leigh Zerboni; Chia-Chi Ku; Carol D Jones; James L Zehnder; Ann M Arvin
Varicella-zoster virus infection of human dorsal root ganglia in vivo.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(18):6490-5.
2005: Hideki Ito; Marvin H Sommer; Leigh Zerboni; Armin Baiker; Bunji Sato; Ruibin Liang; John Hay; William T Ruyechan; Ann M Arvin
Role of the varicella-zoster virus gene product encoded by open reading frame 35 in viral replication in vitro and in differentiated human skin and T cells in vivo.
Journal of virology 2005;79(8):4819-27.
2005: Chia-Chi Ku; Jaya Besser; Allison Abendroth; Charles Grose; Ann M Arvin
Varicella-Zoster virus pathogenesis and immunobiology: new concepts emerging from investigations with the SCIDhu mouse model.
Journal of virology 2005;79(5):2651-8.
2005: Leigh Zerboni; Stewart Hinchliffe; Marvin H Sommer; Hideki Ito; Jaya Besser; Shaye Stamatis; Jason Cheng; Daniel J DiStefano; Nikolai Kraiouchkine; Alan Shaw; Ann M Arvin
Analysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse model.
Virology 2005;332(1):337-46.
2005: Sophie Hambleton; Ann M Arvin
Chickenpox party or varicella vaccine?
Advances in experimental medicine and biology 2005;568():11-24.
2004: Xiaosong He; Monia Draghi; Kutubuddin Mahmood; Tyson H Holmes; George W Kemble; Cornelia L Dekker; Ann M Arvin; Peter Parham; Harry B Greenberg
T cell-dependent production of IFN-gamma by NK cells in response to influenza A virus.
The Journal of clinical investigation 2004;114(12):1812-9.
2004: Jaya Besser; Minako Ikoma; Konstanze Fabel; Marvin H Sommer; Leigh Zerboni; Charles Grose; Ann M Arvin
Differential requirement for cell fusion and virion formation in the pathogenesis of varicella-zoster virus infection in skin and T cells.
Journal of virology 2004;78(23):13293-305.
2004: Jennifer F Moffat; Chengjun Mo; Jason J Cheng; Marvin Sommer; Leigh Zerboni; Shaye Stamatis; Ann M Arvin
Functions of the C-terminal domain of varicella-zoster virus glycoprotein E in viral replication in vitro and skin and T-cell tropism in vivo.
Journal of virology 2004;78(22):12406-15.
2004: Chia-Chi Ku; Leigh Zerboni; Hideki Ito; Brad S Graham; Mark Wallace; Ann M Arvin
Varicella-zoster virus transfer to skin by T Cells and modulation of viral replication by epidermal cell interferon-alpha.
The Journal of experimental medicine 2004;200(7):917-25.
2004: Armin Baiker; Konstanze Fabel; Antonio Cozzio; Leigh Zerboni; Konstanze Fabel; Marvin Sommer; Nobuko Uchida; Dongping He; Irving L Weissman; Ann M Arvin
Varicella-zoster virus infection of human neural cells in vivo.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(29):10792-7.
2004: Ann M Arvin; Patricia Fast; Martin Myers; Stanley Plotkin; Regina Rabinovich
Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(2):233-9.
2004: Hayley Gans; Linda L Yasukawa; Amanda Alderson; Mary Rinki; Ross DeHovitz; Judy A Beeler; Susette Audet; Yvonne Maldonado; Ann M Arvin
Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States.
The Journal of infectious diseases 2004;190(1):83-90.
2004: Sharon F Chen; Wen-Wei Tu; Margaret A Sharp; Eileen Cordoba Tongson; Xiaosong He; Harry B Greenberg; Tyson H Holmes; Zhaoti Wang; George W Kemble; Anne Marie Manganello; Stuart P Adler; Cornelia L Dekker; David B Lewis; Ann M Arvin
Antiviral CD8 T cells in the control of primary human cytomegalovirus infection in early childhood.
The Journal of infectious diseases 2004;189(9):1619-27.
2004: Wenwei Tu; Sharon Chen; Margaret Sharp; Cornelia L Dekker; Anne Marie Manganello; Eileen C Tongson; Holden T Maecker; Tyson H Holmes; Zhaoti Wang; George W Kemble; Stuart Adler; Ann M Arvin; David B Lewis
Persistent and selective deficiency of CD4+ T cell immunity to cytomegalovirus in immunocompetent young children.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(5):3260-7.
2004: Armin Baiker; Christoph P Bagowski; Hideki Ito; Marvin Sommer; Leigh Zerboni; Konstanze Fabel; John Hay; William T Ruyechan; Ann M Arvin
The immediate-early 63 protein of Varicella-Zoster virus: analysis of functional domains required for replication in vitro and for T-cell and skin tropism in the SCIDhu model in vivo.
Journal of virology 2004;78(3):1181-94.
2004: Rosa María Wong-Chew; Rocío Islas-Romero; María de Lourdes García García; Judy A Beeler; Susette Audet; Jose Ignacio Santos-Preciado; Hayley Gans; Linda Lew-Yasukawa; Yvonne Maldonado; Ann M Arvin; José Luis Valdespino-Gómez
Induction of cellular and humoral immunity after aerosol or subcutaneous administration of Edmonston-Zagreb measles vaccine as a primary dose to 12-month-old children.
The Journal of infectious diseases 2004;189(2):254-7.
2004: Hayley Gans; Linda L Yasukawa; Amanda Alderson; Mary Rinki; Ross DeHovitz; Yvonne Maldonado; Ann M Arvin
T cell immunity to measles viral proteins in infants and adults after measles immunization.
Viral immunology 2004;17(2):298-307.
2003: Bunji Sato; Marvin Sommer; Hideki Ito; Ann M Arvin
Requirement of varicella-zoster virus immediate-early 4 protein for viral replication.
Journal of virology 2003;77(22):12369-72.
2003: Hayley Gans; Ross DeHovitz; Bagher Forghani; Judy A Beeler; Yvonne Maldonado; Ann M Arvin
Measles and mumps vaccination as a model to investigate the developing immune system: passive and active immunity during the first year of life.
Vaccine 2003;21(24):3398-405.
2003: Christian R Frey; Margaret A Sharp; Andrew S Min; D Scott Schmid; Vladimir N Loparev; Ann M Arvin
Identification of CD8+ T cell epitopes in the immediate early 62 protein (IE62) of varicella-zoster virus, and evaluation of frequency of CD8+ T cell response to IE62, by use of IE62 peptides after varicella vaccination.
The Journal of infectious diseases 2003;188(1):40-52.
2003: Takahiro Niizuma; Leigh Zerboni; Marvin H Sommer; Hideki Ito; Stewart Hinchliffe; Ann M Arvin
Construction of varicella-zoster virus recombinants from parent Oka cosmids and demonstration that ORF65 protein is dispensable for infection of human skin and T cells in the SCID-hu mouse model.
Journal of virology 2003;77(10):6062-5.
2003: Jaya Besser; Marvin H Sommer; Leigh Zerboni; Christoph P Bagowski; Hideki Ito; Jennifer F Moffat; Chia-Chi Ku; Ann M Arvin
Differentiation of varicella-zoster virus ORF47 protein kinase and IE62 protein binding domains and their contributions to replication in human skin xenografts in the SCID-hu mouse.
Journal of virology 2003;77(10):5964-74.
2003: Bunji Sato; Hideki Ito; Stewart Hinchliffe; Marvin H Sommer; Leigh Zerboni; Ann M Arvin
Mutational analysis of open reading frames 62 and 71, encoding the varicella-zoster virus immediate-early transactivating protein, IE62, and effects on replication in vitro and in skin xenografts in the SCID-hu mouse in vivo.
Journal of virology 2003;77(10):5607-20.
2003: Kathleen Gutierrez; Ann M Arvin
Long term antiviral suppression after treatment for neonatal herpes infection.
The Pediatric infectious disease journal 2003;22(4):371-2.
2003: Xiaosong He; Kutubuddin Mahmood; Holden T Maecker; Tyson H Holmes; George W Kemble; Ann M Arvin; Harry B Greenberg
Analysis of the frequencies and of the memory T cell phenotypes of human CD8+ T cells specific for influenza A viruses.
The Journal of infectious diseases 2003;187(7):1075-84.
2003: Chengjun Mo; Jay Lee; Marvin H Sommer; Ann M Arvin
Varicella-zoster virus infection facilitates VZV glycoprotein E trafficking to the membrane surface of melanoma cells.
Journal of medical virology 2003;70 Suppl 1():S56-8.
2003: Jeremy O Jones; Ann M Arvin
Microarray analysis of host cell gene transcription in response to varicella-zoster virus infection of human T cells and fibroblasts in vitro and SCIDhu skin xenografts in vivo.
Journal of virology 2003;77(2):1268-80.
2003: Hideki Ito; Marvin H Sommer; Leigh Zerboni; Hongying He; Dwayne Boucaud; John Hay; William T Ruyechan; Ann M Arvin
Promoter sequences of varicella-zoster virus glycoprotein I targeted by cellular transactivating factors Sp1 and USF determine virulence in skin and T cells in SCIDhu mice in vivo.
Journal of virology 2003;77(1):489-98.
2002: Chengjun Mo; Jay Lee; Marvin Sommer; Charles Grose; Ann M Arvin
The requirement of varicella zoster virus glycoprotein E (gE) for viral replication and effects of glycoprotein I on gE in melanoma cells.
Virology 2002;304(2):176-86.
2002: Chia-Chi Ku; Jorge A Padilla; Charles Grose; Eugene C Butcher; Ann M Arvin
Tropism of varicella-zoster virus for human tonsillar CD4(+) T lymphocytes that express activation, memory, and skin homing markers.
Journal of virology 2002;76(22):11425-33.
2002: Barry Slobedman; Edward Mocarski; Ann M Arvin; Elizabeth D Mellins; Allison Abendroth
Latent cytomegalovirus down-regulates major histocompatibility complex class II expression on myeloid progenitors.
Blood 2002;100(8):2867-73.
2002: Mark Quinlivan; KHIDIR HAWRAMI; Winsome Y Barrett-Muir; Peter Aaby; Ann M Arvin; Vincent T Chow; T Jacob John; Patrick Matondo; Malik Peiris; Anja Poulsen; Marilda Siqueira; Michiaki Takahashi; Yamima Talukder; Koichi Yamanishi; Mary Leedham-Green; Fiona T Scott; Sara L Thomas; Judith Breuer
The molecular epidemiology of varicella-zoster virus: evidence for geographic segregation.
The Journal of infectious diseases 2002;186(7):888-94.
2002: Jennifer F Moffat; Hideki Ito; Marvin Sommer; Shannon Taylor; Ann M Arvin
Glycoprotein I of varicella-zoster virus is required for viral replication in skin and T cells.
Journal of virology 2002;76(16):8468-71.
2002: Atsuko Hata; Hideomi Asanuma; Mary Rinki; Margaret Sharp; Ruby M Wong; Karl G Blume; Ann M Arvin
Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants.
The New England journal of medicine 2002;347(1):26-34.
2002: Ann M Arvin
Varlirix (GlaxoSmithKline).
Current opinion in investigational drugs (London, England : 2000) 2002;3(7):996-9.
2002: Ann M Arvin
Debate: the argument against. Should all pregnant women be offered type-specific serological screening for HSV infection?
Herpes : the journal of the IHMF 2002;9(2):48-50.
2002: Ann M Arvin; Margaret Sharp; Melinda Moir; Paul R Kinchington; Majid Sadeghi-Zadeh; William T Ruyechan; John Hay
Memory cytotoxic T cell responses to viral tegument and regulatory proteins encoded by open reading frames 4, 10, 29, and 62 of varicella-zoster virus.
Viral immunology 2002;15(3):507-16.
2002: Ann M Arvin
Antiviral therapy for varicella and herpes zoster.
Seminars in pediatric infectious diseases 2002;13(1):12-21.
2001: Hayley Gans; Linda L Yasukawa; Mary Rinki; Ross DeHovitz; Bagher Forghani; Judy A Beeler; Susette Audet; Yvonne Maldonado; Ann M Arvin
Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months.
The Journal of infectious diseases 2001;184(7):817-26.
2001: Marvin H Sommer; E Zagha; O K Serrano; Chia-Chi Ku; Leigh Zerboni; Armin Baiker; R Santos; ML Spengler; J Lynch; Charles Grose; William T Ruyechan; John Hay; Ann M Arvin
Mutational analysis of the repeated open reading frames, ORFs 63 and 70 and ORFs 64 and 69, of varicella-zoster virus.
Journal of virology 2001;75(17):8224-39.
2001: Ann M Arvin
Varicella-zoster virus: molecular virology and virus-host interactions.
Current opinion in microbiology 2001;4(4):442-9.
2001: Ann M Arvin
Varicella vaccine: genesis, efficacy, and attenuation.
Virology 2001;284(2):153-8.
2001: Allison Abendroth; I Lin; Barry Slobedman; H Ploegh; Ann M Arvin
Varicella-zoster virus retains major histocompatibility complex class I proteins in the Golgi compartment of infected cells.
Journal of virology 2001;75(10):4878-88.
2001: A Hata; Leigh Zerboni; Marvin Sommer; AA Kaspar; Carol Clayberger; Alan Krensky; Ann M Arvin
Granulysin blocks replication of varicella-zoster virus and triggers apoptosis of infected cells.
Viral immunology 2001;14(2):125-33.
2001: Allison Abendroth; Ann M Arvin
Immune evasion mechanisms of varicella-zoster virus.
Archives of virology. Supplementum 2001;(17):99-107.
2001: Z H Wang; Michael D Gershon; Octavian Lungu; Zhenglun (Jerry) Zhu; S Mallory; Ann M Arvin; Anne A Gershon
Essential role played by the C-terminal domain of glycoprotein I in envelopment of varicella-zoster virus in the trans-Golgi network: interactions of glycoproteins with tegument.
Journal of virology 2001;75(1):323-40.
2000: Chengjun Mo; EE Schneeberger; Ann M Arvin
Glycoprotein E of varicella-zoster virus enhances cell-cell contact in polarized epithelial cells.
Journal of virology 2000;74(23):11377-87.
2000: RA Santos; CC Hatfield; N L Cole; Jorge A Padilla; Jennifer F Moffat; Ann M Arvin; William T Ruyechan; John Hay; Charles Grose
Varicella-zoster virus gE escape mutant VZV-MSP exhibits an accelerated cell-to-cell spread phenotype in both infected cell cultures and SCID-hu mice.
Virology 2000;275(2):306-17.
2000: Leigh Zerboni; Marvin Sommer; C F Ware; Ann M Arvin
Varicella-zoster virus infection of a human CD4-positive T-cell line.
Virology 2000;270(2):278-85.
2000: H Asanuma; Margaret Sharp; Holden T Maecker; Vernon C Maino; Ann M Arvin
Frequencies of memory T cells specific for varicella-zoster virus, herpes simplex virus, and cytomegalovirus by intracellular detection of cytokine expression.
The Journal of infectious diseases 2000;181(3):859-66.
2000: Allison Abendroth; Barry Slobedman; E Lee; Elizabeth D Mellins; M Wallace; Ann M Arvin
Modulation of major histocompatibility class II protein expression by varicella-zoster virus.
Journal of virology 2000;74(4):1900-7.
2000: Ann M Arvin
Varicella-Zoster virus: pathogenesis, immunity, and clinical management in hematopoietic cell transplant recipients.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(3):219-30.
1999: Allison Abendroth; Barry Slobedman; Matthew L Springer; Helen M Blau; Ann M Arvin
Analysis of immune responses to varicella zoster viral proteins induced by DNA vaccination.
Antiviral research 1999;44(3):179-92.
1999: Avinash K Shetty; Ann M Arvin; Kathleen Gutierrez
Nocardia farcinica pneumonia in chronic granulomatous disease.
Pediatrics 1999;104(4 Pt 1):961-4.
1999: Kathleen Gutierrez; Meira S Falkovitz-Halpern; Yvonne Maldonado; Ann M Arvin
The epidemiology of neonatal herpes simplex virus infections in California from 1985 to 1995.
The Journal of infectious diseases 1999;180(1):199-202.
1999: Hayley Gans; Yvonne Maldonado; Linda L Yasukawa; Judy A Beeler; Susette Audet; Mary Rinki; Ross DeHovitz; Ann M Arvin
IL-12, IFN-gamma, and T cell proliferation to measles in immunized infants.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(9):5569-75.
1999: Chengjun Mo; J Suen; Marvin Sommer; Ann M Arvin
Characterization of Varicella-Zoster virus glycoprotein K (open reading frame 5) and its role in virus growth.
Journal of virology 1999;73(5):4197-207.
1999: Allison Abendroth; Ann M Arvin
Varicella-zoster virus immune evasion.
Immunological reviews 1999;168():143-56.
1999: Ann M Arvin; S Mallory; Jennifer F Moffat
Development of recombinant varicella-zoster virus vaccines.
Contributions to microbiology 1999;3():193-200.
1999: Ann M Arvin
Chickenpox (varicella).
Contributions to microbiology 1999;3():96-110.
1999: Ann M Arvin
Management of varicella-zoster virus infections in children.
Advances in experimental medicine and biology 1999;458():167-74.
1999: Darlene E Jenkins; Linda L Yasukawa; R Bergen; Claudia Benike; Edgar G Engleman; Ann M Arvin
Comparison of primary sensitization of naive human T cells to varicella-zoster virus peptides by dendritic cells in vitro with responses elicited in vivo by varicella vaccination.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(1):560-7.
1998: Philip S LaRussa; Sharon Steinberg; Ann M Arvin; D Dwyer; M Burgess; M Menegus; K Rekrut; K Yamanishi; Anne A Gershon
Polymerase chain reaction and restriction fragment length polymorphism analysis of varicella-zoster virus isolates from the United States and other parts of the world.
The Journal of infectious diseases 1998;178 Suppl 1():S64-6.
1998: Catherine Sadzot; Ann M Arvin; Bernard Rentier
Varicella-zoster virus IE63, a virion component expressed during latency and acute infection, elicits humoral and cellular immunity.
The Journal of infectious diseases 1998;178 Suppl 1():S43-7.
1998: Darlene E Jenkins; Linda L Yasukawa; Claudia Benike; Edgar G Engleman; Ann M Arvin
Isolation and utilization of human dendritic cells from peripheral blood to assay an in vitro primary immune response to varicella-zoster virus peptides.
The Journal of infectious diseases 1998;178 Suppl 1():S39-42.
1998: S Mallory; Marvin Sommer; Ann M Arvin
Analysis of the glycoproteins I and E of varicella-zoster virus (VZV) using deletional mutations of VZV cosmids.
The Journal of infectious diseases 1998;178 Suppl 1():S22-6.
1998: Darlene E Jenkins; R L Redman; E M Lam; C Liu; I Lin; Ann M Arvin
Interleukin (IL)-10, IL-12, and interferon-gamma production in primary and memory immune responses to varicella-zoster virus.
The Journal of infectious diseases 1998;178(4):940-8.
1998: Jennifer F Moffat; Leigh Zerboni; Marvin H Sommer; Thomas C Heineman; Jeffrey I Cohen; H Kaneshima; Ann M Arvin
The ORF47 and ORF66 putative protein kinases of varicella-zoster virus determine tropism for human T cells and skin in the SCID-hu mouse.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(20):11969-74.
1998: Hayley Gans; Ann M Arvin; J Galinus; Laura Logan; Ross DeHovitz; Yvonne Maldonado
Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months.
JAMA : the journal of the American Medical Association 1998;280(6):527-32.
1998: Leigh Zerboni; S Nader; K Aoki; Ann M Arvin
Analysis of the persistence of humoral and cellular immunity in children and adults immunized with varicella vaccine.
The Journal of infectious diseases 1998;177(6):1701-4.
1998: Jennifer F Moffat; Leigh Zerboni; Paul R Kinchington; Charles Grose; H Kaneshima; Ann M Arvin
Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse.
Journal of virology 1998;72(2):965-74.
1997: S Mallory; Marvin Sommer; Ann M Arvin
Mutational analysis of the role of glycoprotein I in varicella-zoster virus replication and its effects on glycoprotein E conformation and trafficking.
Journal of virology 1997;71(11):8279-88.
1997: Catherine Sadzot; Paul R Kinchington; S Debrus; Bernard Rentier; Ann M Arvin
Recognition of the latency-associated immediate early protein IE63 of varicella-zoster virus by human memory T lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(6):2802-6.
1997: R L Redman; S Nader; Leigh Zerboni; C Liu; Ruby M Wong; Byron W Brown; Ann M Arvin
Early reconstitution of immunity and decreased severity of herpes zoster in bone marrow transplant recipients immunized with inactivated varicella vaccine.
The Journal of infectious diseases 1997;176(3):578-85.
1997: Ann M Arvin
Live attenuated varicella vaccine.
Pediatric annals 1997;26(6):384-8.
1997: P W Lowry; C M Koropchak; C Y Choi; Edward Mocarski; E R Kern; Paul R Kinchington; Ann M Arvin
The synthesis and immunogenicity of varicella-zoster virus glycoprotein E and immediate-early protein (IE62) expressed in recombinant herpes simplex virus-1.
Antiviral research 1997;33(3):187-200.
1997: Ann M Arvin
The varicella vaccine.
Current clinical topics in infectious diseases 1997;17():110-46.
1996: M A Carmack; Linda L Yasukawa; S Y Chang; C Tran; F Saldana; Ann M Arvin; Charles G Prober
T cell recognition and cytokine production elicited by common and type-specific glycoproteins of herpes simplex virus type 1 and type 2.
The Journal of infectious diseases 1996;174(5):899-906.
1996: Ann M Arvin
Immune responses to varicella-zoster virus.
Infectious disease clinics of North America 1996;10(3):529-70.
1996: Ann M Arvin
Varicella-zoster virus.
Clinical microbiology reviews 1996;9(3):361-81.
1996: Ann M Arvin
Varicella-zoster virus: overview and clinical manifestations.
Seminars in dermatology 1996;15(2 Suppl 1):4-7.
1996: Ann M Arvin; A A Gershon
Live attenuated varicella vaccine.
Annual review of microbiology 1996;50():59-100.
1996: Ann M Arvin; Jennifer F Moffat; R Redman
Varicella-zoster virus: aspects of pathogenesis and host response to natural infection and varicella vaccine.
Advances in virus research 1996;46():263-309.
1995: Ann M Arvin
Aspects of the host response to varicella-zoster virus: a review of recent observations.
Neurology 1995;45(12 Suppl 8):S36-7.
1995: Jennifer F Moffat; M D Stein; H Kaneshima; Ann M Arvin
Tropism of varicella-zoster virus for human CD4+ and CD8+ T lymphocytes and epidermal cells in SCID-hu mice.
Journal of virology 1995;69(9):5236-42.
1995: S Nader; R Bergen; M Sharp; Ann M Arvin
Age-related differences in cell-mediated immunity to varicella-zoster virus among children and adults immunized with live attenuated varicella vaccine.
The Journal of infectious diseases 1995;171(1):13-7.
1993: C Sabella; P W Lowry; G M Abbruzzi; C M Koropchak; Paul R Kinchington; M Sadegh-Zadeh; J Hay; W T Ruyechan; Ann M Arvin
Immunization with the immediate-early tegument protein (open reading frame 62) of varicella-zoster virus protects guinea pigs against virus challenge.
Journal of virology 1993;67(12):7673-6.
1993: Ann M Arvin; Charles G Prober
Analysis of the epidemiology and pathogenesis of herpes simplex virus (HSV) infections in pregnant women and infants using the HSV-2 glycoprotein G antibody assay.
Infectious agents and disease 1993;2(6):375-82.
1993: M A Carmack; J Twiss; D R Enzmann; M D Amylon; Ann M Arvin
Multifocal leukoencephalitis caused by varicella-zoster virus in a child with leukemia: successful treatment with acyclovir.
The Pediatric infectious disease journal 1993;12(5):402-6.
1993: F D Boucher; Linda L Yasukawa; K Kerns; M Kastelein; Ann M Arvin; Charles G Prober
Detection of antibodies to herpes simplex virus type 2 with a mammalian cell line expressing glycoprotein gG-2.
Clinical and diagnostic virology 1993;1(1):29-38.
1993: P W Lowry; C Sabella; C M Koropchak; B N Watson; H M Thackray; G M Abbruzzi; Ann M Arvin
Investigation of the pathogenesis of varicella-zoster virus infection in guinea pigs by using polymerase chain reaction.
The Journal of infectious diseases 1993;167(1):78-83.
1992: Charles G Prober; L Corey; Zane Brown; P A Hensleigh; L M Frenkel; Yvonne Bryson; R J Whitley; Ann M Arvin
The management of pregnancies complicated by genital infections with herpes simplex virus.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1992;15(6):1031-8.
1992: Louie Naumovski; J P Quinn; D Miyashiro; M Patel; K Bush; S B Singer; D Graves; T Palzkill; Ann M Arvin
Outbreak of ceftazidime resistance due to a novel extended-spectrum beta-lactamase in isolates from cancer patients.
Antimicrobial agents and chemotherapy 1992;36(9):1991-6.
1992: Ann M Arvin
Cell-mediated immunity to varicella-zoster virus.
The Journal of infectious diseases 1992;166 Suppl 1():S35-41.
1992: M Sharp; K Terada; A Wilson; S Nader; P E Kinchington; W T Ruyechan; J Hay; Ann M Arvin
Kinetics and viral protein specificity of the cytotoxic T lymphocyte response in healthy adults immunized with live attenuated varicella vaccine.
The Journal of infectious diseases 1992;165(5):852-8.
1992: J A Kulhanjian; V Soroush; D S Au; R N Bronzan; Linda L Yasukawa; L E Weylman; Ann M Arvin; Charles G Prober
Identification of women at unsuspected risk of primary infection with herpes simplex virus type 2 during pregnancy.
The New England journal of medicine 1992;326(14):916-20.
1992: P W Lowry; S Solem; B N Watson; C M Koropchak; H M Thackray; Paul R Kinchington; W T Ruyechan; Paul D Ling; J Hay; Ann M Arvin
Immunity in strain 2 guinea-pigs inoculated with vaccinia virus recombinants expressing varicella-zoster virus glycoproteins I, IV, V or the protein product of the immediate early gene 62.
The Journal of general virology 1992;73 ( Pt 4)():811-9.
1992: Ann M Arvin; Charles G Prober
Herpes simplex virus infections: the genital tract and the newborn.
Pediatrics in review / American Academy of Pediatrics 1992;13(3):107-12.
1992: C M Koropchak; G Graham; J Palmer; M Winsberg; S F Ting; M Wallace; Charles G Prober; Ann M Arvin
Investigation of varicella-zoster virus infection by polymerase chain reaction in the immunocompetent host with acute varicella.
The Journal of infectious diseases 1992;165(1):188.
1992: A Wilson; M Sharp; C M Koropchak; S F Ting; Ann M Arvin
Subclinical varicella-zoster virus viremia, herpes zoster, and T lymphocyte immunity to varicella-zoster viral antigens after bone marrow transplantation.
The Journal of infectious diseases 1992;165(1):119-26.
1992: Paul R Kinchington; J K Hougland; Ann M Arvin; W T Ruyechan; J Hay
The varicella-zoster virus immediate-early protein IE62 is a major component of virus particles.
Journal of virology 1992;66(1):359-66.
1991: Ann M Arvin
Relationships between maternal immunity to herpes simplex virus and the risk of neonatal herpesvirus infection.
Reviews of infectious diseases 1991;13 Suppl 11():S953-6.
1991: C M Koropchak; G Graham; J Palmer; M Winsberg; S F Ting; M Wallace; Charles G Prober; Ann M Arvin
Investigation of varicella-zoster virus infection by polymerase chain reaction in the immunocompetent host with acute varicella.
The Journal of infectious diseases 1991;163(5):1016-22.
1991: L M Frenkel; Zane Brown; Yvonne Bryson; L Corey; J D Unadkat; P A Hensleigh; Ann M Arvin; Charles G Prober; James D Connor
Pharmacokinetics of acyclovir in the term human pregnancy and neonate.
American journal of obstetrics and gynecology 1991;164(2):569-76.
1991: P S Diaz; D Au; S Smith; M Amylon; M Link; S Smith; Ann M Arvin
Lack of transmission of the live attenuated varicella vaccine virus to immunocompromised children after immunization of their siblings.
Pediatrics 1991;87(2):166-70.
1991: R E Bergen; M Sharp; A Sanchez; A K Judd; Ann M Arvin
Human T cells recognize multiple epitopes of an immediate early/tegument protein (IE62) and glycoprotein I of varicella zoster virus.
Viral immunology 1991;4(3):151-66.
1991: Ann M Arvin; M Sharp; S Smith; C M Koropchak; P S Diaz; Paul R Kinchington; W Ruyechan; J Hay
Equivalent recognition of a varicella-zoster virus immediate early protein (IE62) and glycoprotein I by cytotoxic T lymphocytes of either CD4+ or CD8+ phenotype.
Journal of immunology (Baltimore, Md. : 1950) 1991;146(1):257-64.
1990: R E Bergen; P S Diaz; Ann M Arvin
The immunogenicity of the Oka/Merck varicella vaccine in relation to infectious varicella-zoster virus and relative viral antigen content.
The Journal of infectious diseases 1990;162(5):1049-54.
1990: D A Hardy; Ann M Arvin; Linda L Yasukawa; R N Bronzan; David M Lewinsohn; P A Hensleigh; Charles G Prober
Use of polymerase chain reaction for successful identification of asymptomatic genital infection with herpes simplex virus in pregnant women at delivery.
The Journal of infectious diseases 1990;162(5):1031-5.
1990: Ann M Arvin; Charles G Prober
Herpes simplex virus infections.
The Pediatric infectious disease journal 1990;9(10):765-7.
1990: F D Boucher; Linda L Yasukawa; R N Bronzan; P A Hensleigh; Ann M Arvin; Charles G Prober
A prospective evaluation of primary genital herpes simplex virus type 2 infections acquired during pregnancy.
The Pediatric infectious disease journal 1990;9(7):499-504.
1990: Ann M Arvin; C M Koropchak; M Sharp; R Bergen; P S Diaz
The T-lymphocyte response to varicella-zoster viral proteins.
Advances in experimental medicine and biology 1990;278():71-81.
1989: S Kohl; M S West; Charles G Prober; W M Sullender; L S Loo; Ann M Arvin
Neonatal antibody-dependent cellular cytotoxic antibody levels are associated with the clinical presentation of neonatal herpes simplex virus infection.
The Journal of infectious diseases 1989;160(5):770-6.
1989: C M Koropchak; S M Solem; P S Diaz; Ann M Arvin
Investigation of varicella-zoster virus infection of lymphocytes by in situ hybridization.
Journal of virology 1989;63(5):2392-5.
1989: P S Diaz; S Smith; E Hunter; Ann M Arvin
T lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine.
Journal of immunology (Baltimore, Md. : 1950) 1989;142(2):636-41.
1989: C W Wilson; David K Stevenson; Ann M Arvin
A concurrent epidemic of respiratory syncytial virus and echovirus 7 infections in an intensive care nursery.
The Pediatric infectious disease journal 1989;8(1):24-9.
1988: P S Diaz; S Smith; E Hunter; Ann M Arvin
Immunity to whole varicella-zoster virus antigen and glycoproteins I and p170: relation to the immunizing regimen of live attenuated varicella vaccine.
The Journal of infectious diseases 1988;158(6):1245-52.
1988: Charles G Prober; P A Hensleigh; F D Boucher; Linda L Yasukawa; D S Au; Ann M Arvin
Use of routine viral cultures at delivery to identify neonates exposed to herpes simplex virus.
The New England journal of medicine 1988;318(14):887-91.
1988: Ann M Arvin
Antiviral treatment of herpes simplex infection in neonates and pregnant women.
Journal of the American Academy of Dermatology 1988;18(1 Pt 2):200-3.
1988: W M Sullender; Linda L Yasukawa; M Schwartz; L Pereira; P A Hensleigh; Charles G Prober; Ann M Arvin
Type-specific antibodies to herpes simplex virus type 2 (HSV-2) glycoprotein G in pregnant women, infants exposed to maternal HSV-2 infection at delivery, and infants with neonatal herpes.
The Journal of infectious diseases 1988;157(1):164-71.
1987: W M Sullender; Ann M Arvin; P S Diaz; J D Connor; R Straube; Wayne M Dankner; M J Levin; S Weller; M R Blum; S Chapman
Pharmacokinetics of acyclovir suspension in infants and children.
Antimicrobial agents and chemotherapy 1987;31(11):1722-6.
1987: Ann M Arvin; S M Solem; C M Koropchak; E Kinney-Thomas; S G Paryani
Humoral and cellular immunity to varicella-zoster virus glycoprotein gpI and to a non-glycosylated protein, p170, in the strain 2 guinea-pig.
The Journal of general virology 1987;68 ( Pt 9)():2449-54.
1987: B Noorbehesht; D R Enzmann; W Sullender; J S Bradley; Ann M Arvin
Neonatal herpes simplex encephalitis: correlation of clinical and CT findings.
Radiology 1987;162(3):813-9.
1987: Charles G Prober; W M Sullender; Linda L Yasukawa; D S Au; A S Yeager; Ann M Arvin
Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections.
The New England journal of medicine 1987;316(5):240-4.
1987: W M Sullender; J L Miller; Linda L Yasukawa; J S Bradley; S B Black; A S Yeager; Ann M Arvin
Humoral and cell-mediated immunity in neonates with herpes simplex virus infection.
The Journal of infectious diseases 1987;155(1):28-37.
1986: Ann M Arvin; P A Hensleigh; Charles G Prober; D S Au; Linda L Yasukawa; A E Wittek; P E Palumbo; S G Paryani; A S Yeager
Failure of antepartum maternal cultures to predict the infant's risk of exposure to herpes simplex virus at delivery.
The New England journal of medicine 1986;315(13):796-800.
1986: Ann M Arvin; C M Koropchak; B R Williams; F Carl Grumet; S K Foung
Early immune response in healthy and immunocompromised subjects with primary varicella-zoster virus infection.
The Journal of infectious diseases 1986;154(3):422-9.
1986: Ann M Arvin; E Kinney-Thomas; K Shriver; C Grose; C M Koropchak; E Scranton; A E Wittek; P S Diaz
Immunity to varicella-zoster viral glycoproteins, gp I (gp 90/58) and gp III (gp 118), and to a nonglycosylated protein, p 170.
Journal of immunology (Baltimore, Md. : 1950) 1986;137(4):1346-51.
1985: Steven K H Foung; S Perkins; C Koropchak; D M Fishwild; A E Wittek; E G Engleman; F Carl Grumet; Ann M Arvin
Human monoclonal antibodies neutralizing varicella-zoster virus.
The Journal of infectious diseases 1985;152(2):280-5.
1984: P E Palumbo; Ann M Arvin; C M Koropchak; A E Wittek
Investigation of varicella-zoster virus-infected cell proteins that elicit antibody production during primary varicella using the immune transfer method.
The Journal of general virology 1984;65 ( Pt 12)():2141-7.
1984: S G Paryani; Ann M Arvin; C M Koropchak; M B Dobkin; A E Wittek; M D Amylon; M D Budinger
Comparison of varicella zoster antibody titers in patients given intravenous immune serum globulin or varicella zoster immune globulin.
The Journal of pediatrics 1984;105(2):200-5.
1984: S G Paryani; Ann M Arvin; C M Koropchak; A E Wittek; M D Amylon; M B Dobkin; M D Budinger
Varicella zoster antibody titers after the administration of intravenous immune serum globulin or varicella zoster immune globulin.
The American journal of medicine 1984;76(3A):124-7.
1983: A E Wittek; P S Cohen; Ann M Arvin; S D Smith; C M Koropchak; E De Clercq
Effects of (E)-5-(2-bromovinyl)-2'-deoxyuridine on proliferation of human fibroblasts, peripheral blood mononuclear cells, and granulocyte-monocyte progenitor cells in vitro.
Antimicrobial agents and chemotherapy 1983;24(5):803-6.
1983: A E Wittek; Ann M Arvin; C M Koropchak
Serum immunoglobulin A antibody to varicella-zoster virus in subjects with primary varicella and herpes zoster infections and in immune subjects.
Journal of clinical microbiology 1983;18(5):1146-9.
1983: Ann M Arvin; C M Koropchak; A E Wittek
Immunologic evidence of reinfection with varicella-zoster virus.
The Journal of infectious diseases 1983;148(2):200-5.
1982: A S Yeager; Ann M Arvin; P A Hensleigh
The validity of reporting results of cultures for herpes simplex virus after four days.
The Journal of reproductive medicine 1982;27(8):447-8.
1981: A S Yeager; Carl Grumet; E B Hafleigh; Ann M Arvin; J S Bradley; Charles G Prober
Prevention of transfusion-acquired cytomegalovirus infections in newborn infants.
The Journal of pediatrics 1981;98(2):281-7.